Clinical Trial Update: Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a dexmedetomidine transdermal system for postoperative analgesia after abdominoplasty has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Dexmedetomidine Transdermal System (dexmedetomidine)

Snippet

Sponsor: Teikoku Pharma USA, Inc. | Conditions: Pain, Postoperative | Phase 2 | Status: TERMINATED